Clinical Trials Sponsored by Mologic Ltd

Total 17225 results

Singapore General Hospital
Mologic Ltd

Completed

Point-of-care Test for Diagnosis of Peritonitis in Peritoneal Dialysis Patients (Periplex)

Peritonitis

Singapore
Mologic Ltd
University Hospitals, Leicester

Terminated

COPD Exacerbation Alert System With urinE anaLysis Using the HEADSTART Device (COPE-WEL)

COPD Exacerbation

United Kingdom
Hologic, Inc.
QST Consultations, Ltd.

Terminated

Safety & Efficacy Study of the Adiana System for Women Who Desire Permanent Birth Control (Sterilization) (EASE)

Reproductive Sterilization

United States, Australia, Mexico
Mologic Ltd
Heart of England NHS Foundation Trust

Completed

Study of Urinary Predictors of Exacerbations by Biomarkers in Cystic Fibrosis (SUPERB-CF)

Cystic Fibrosis

United Kingdom
Mologic Ltd
University College London Hospitals; Innovate UK

Unknown

The Performance of the Mologic Biomarker Panel in Infection

Sepsis | Infection

United Kingdom
Hologic, Inc.

Completed

A Prospective, Multi-site Clinical Study to Collect User Feedback Using Affirm® Contrast Biopsy

Breast Cancer

United States
Hologic, Inc.

Completed

A Pilot Study - Comparison of Two Hologic 3D Mammography Systems

Breast Cancer
Hologic, Inc.

Completed

MyoSure Hysteroscopic Tissue Removal System Registry Study

Polyps | Uterine Fibroids

United States
Hologic, Inc.

Completed

Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects

Herpes Simplex Infections

United States
Hologic, Inc.

Completed

Dual-energy Contrast-enhanced (2D and 3D Mammography Versus Contrast-enhanced MRI)- A Pilot Study

Breast Cancer

United States
Hologic, Inc.

Completed

Clinical Evaluation of the Interlace Medical Hysteroscopic Morcellator

Infertility | Abnormal Uterine Bleeding
Hologic, Inc.

Completed

Comparison of Fetal Fibronectin (fFN) Specimen Collection Methodologies: With Speculum Versus Without Speculum (SpecOp)

Preterm Delivery

United States
Hologic, Inc.

Completed

Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal System

Polyps | Uterine Fibroids

United States
Hologic, Inc.

Recruiting

Prospective Case Collection Study for New Mammography Technologies

Mammography

United States
Hologic, Inc.

Completed

Evaluating Image Quality and Comfort of an Investigational Curved Paddle Compared to a Standard Paddle

Breast Cancer

United States
Hologic, Inc.

Completed

A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System

Breast Cancer Female

United States
Hologic, Inc.

Unknown

Post Approval NovaSure Essure Labeling Study (PANEL)

Menorrhagia

United States
Hologic, Inc.

Withdrawn

Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test

Intra-Amniotic Infection of Foetus

United States
Hologic, Inc.

Completed

HOME Study: Hysteroscopic Office Myomectomy Evaluation (HOME)

Polyps | Uterine Fibroids

United States
Hologic, Inc.

Terminated

Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples

Gonorrhea | Chlamydia Trachomatis

United States
Hologic, Inc.

Terminated

Adiana Post-Approval Clinical Study (APACS) (APACS)

Women Contraception

United States
Hologic, Inc.

Completed

A Comparison of the 15 and 30 Acquisition Angle Breast Tomosynthesis Mammography for Breast Abnormalities

Breast Cancer

United States
Hologic, Inc.

Completed

Evaluation of a 3-D Tomosynthesis Mammography System Used in Conjunction With Conventional 2-D Digital Mammography

Breast Cancer

United States
Hologic, Inc.

Completed

Brevera™ Breast Biopsy System Data Collection Study

Breast Cancer Female

Netherlands, France, Germany, Italy, Spain, United Kingdom
Hologic, Inc.

Completed

Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay (HBVQuant)

Hepatitis B, Chronic

United States, Canada, Germany, Hungary, Turkey, Australia, Bulgaria, Italy, New Zealand, Romania
Hologic, Inc.

Completed

Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing

Hepatitis C

United States, Puerto Rico
Hologic, Inc.

Unknown

fFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm Birth

Pre-term Birth

United States
Hologic, Inc.

Unknown

Multicenter Hologic Tomosynthesis Study

Breast Cancer

United States
Institut de Myologie, France
Aparito Ltd.

Recruiting

Feasibility, Validation and Application of Digital Tools for the Follow-up of Neuromuscular Patient Mobility in Daily Living (DT4RD)

Neuromuscular Diseases

France, United Kingdom
Hologic Deutschland GmbH

Completed

Comparison of the Hologic Genius Digital Diagnostics System With the ThinPrep Imaging System

Cervical Cancer Screening

Germany
Hologic Deutschland GmbH

Recruiting

Comparison of the Hologic Genius Digital Diagnostics System With the Liquid-based Cytology (LBC) Manual Microscopy

Cervical Cancer Screening

Germany
Hologic, Inc.
NAMSA

Suspended

RF Ablation of the Trigone for the Treatment of UUI (TRANSFORM)

Urgent Urinary Incontinence

United States
Pediatrix
Hologic, Inc.

Withdrawn

VF Test for Prediction of Extremely PTB After Cerclage

Preterm Birth | Infection
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Recruiting

Clinical Trial of Mica

Latent Tuberculosis Infection

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Recruiting

Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)

Coronavirus Disease 2019

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)

Coronavirus

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split Vaccine

Prevention of Influenza

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine

Coronavirus Disease 2019

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Active, not recruiting

Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)

Acute Gastroenteritis

China
Arthro-Anda Tianjin Biologic Technology Co., Ltd.

Unknown

Study on Efficacy and Safety of CaReSR-1S to Repair Cartilage Defects of the Knee

Cartilage Defects

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Not yet recruiting

Clinical Study of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)

Coronavirus
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Suspended

A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)

Tuberculosis

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

To Evaluate the Immunogenicity and Safety of Sequential Booster Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cells) for SARS-CoV-2

COVID-19

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Clinical Study of BCG Vaccine for Intradermal Injection

Tuberculosis

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)

Tuberculosis

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Active, not recruiting

Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)

Coronavirus Disease 2019

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity

Coronavirus Disease 2019

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Unknown

Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old)

Coronavirus

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Recruiting

BCG for Therapeutic Use Phase I Clinical Trial

Non-muscular Invasive Bladder Cancer

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Recruiting

Phase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein

Latent Tuberculosis Infection

China

3

Subscribe